Synthon-Bagó was established through an agreement between the Dutch company Synthon and the Argentine company Bagó, with the aim of becoming the first Argentine pharmaceutical company dedicated exclusively to the treatment of Multiple Sclerosis.
Synthon is an international company headquartered in Nijmegen, the Netherlands. Since 2007, it has developed its biotechnology area, specializing in autoimmune diseases and oncology. It offers products approved by more than 80 regulatory agencies worldwide.
Commercial offices
Pharmaceutical plant
10 MS REPS
1 MSL
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
Based on production quality, research and development, and the efficiency of its technical and commercial service, Biogénesis – Bagó has become an international leader in animal health.
The distribution of pharmaceuticals is a key factor of this industry and a competitve advantage of the Bagó Group, with 3 distributors strategically located in Latin America and equipped with state-of-the-art technology.
Victoria Seguros, is a solid and responsible insurance company, with a vast track record and high reputation in the market. It offers a wide range of top quality products.
The pharmochemical production of active pharmaceutical ingredients from chemical inputs is carried out at the Grupo Bagó industrial plant, specifically designed for these types of processes.
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
Based on production quality, research and development, and the efficiency of its technical and commercial service, Biogénesis – Bagó has become an international leader in animal health.
The distribution of pharmaceuticals is a key factor of this industry and a competitve advantage of the Bagó Group, with 3 distributors strategically located in Latin America and equipped with state-of-the-art technology.
Victoria Seguros, is a solid and responsible insurance company, with a vast track record and high reputation in the market. It offers a wide range of top quality products.
The pharmochemical production of active pharmaceutical ingredients from chemical inputs is carried out at the Grupo Bagó industrial plant, specifically designed for these types of processes.
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
